ERNEST HAWK to Half-Life
This is a "connection" page, showing publications ERNEST HAWK has written about Half-Life.
Connection Strength
0.011
-
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res. 2000 Jan; 6(1):78-89.
Score: 0.011
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.